Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential canonical 4 channel (TRPC4) is a non-selective, calcium-permeable cation channel of the TRP superfamily encoded by the *TRPC4* gene. It forms homo- or heterotetrameric assemblies (e.g., with TRPC1) and is activated by receptor-coupled signaling pathways (especially Gq- and Gi-coupled receptors) as well as tyrosine kinases. TRPC4 plays key physiological roles in calcium signaling, neuronal excitability, neurotransmitter release, vascular tone, and cell proliferation. It is highly expressed in corticolimbic brain regions and endothelial cells and is implicated in neuropsychiatric disorders, epilepsy, cardiovascular regulation, and cancer biology. Experimentally, several small-molecule inhibitors and endogenous proteins (such as calmodulin) modulate TRPC4 activity, making it a potential therapeutic target in multiple disease contexts[1][3][4][5][7].
Inhibition of channel activity (e.g., pyridazinone-based inhibitors block Ca²⁺ influx)[5]; Modulation via protein–protein interactions (e.g., CaM binding alters gating)[5]; Activation via receptor-operated (G-protein-coupled) or store-operated mechanisms
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential canonical 4 channel (TRPC4).